EastGate Acquisitions Presents An Introduction To Its Self-Emulsifying Platform Delivery System For Enhancing Bioavailability Of Biologically Active Compounds

EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company aiming to make use of innovations in drug delivery for the development of improved novel formulations and alternative dosage forms for existing biologically active molecules.
http://bit.ly/1klSUk4